20 September 2016

Alnylam commits to opening EU hub in UK

Alnylam has delivered a post-Brexit boost to the British biopharma sector by committing to housing its European clinical trials and operations headquarters in Maidenhead. The decision flies in the face of concerns about Britain’s attractiveness to overseas drugmakers in the wake of the referendum, although there are reasons to think Alnylam may be the exception rather than the rule. Source: Fierce Biotech 20/9/2016

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).